medigraphic.com

2015, Number 4

Next >>

Rev Mex Med Repro 2015; 7.8 (4)

The rise of letrozole as the drug of election in the treatment of polycystic ovary syndrome

Piña-Aguilar RE, Sondón-García ZG, Moreno-García JD

Language: Spanish
References: 15
Page: 141-144
PDF size: 274.29 Kb.


Text Extraction

No abstract


REFERENCES

  1. Tredway D, Schertz JC, Bock D, Hemsey G, Diamond MP. Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study. Fertil Steril 2011;95:1725-9.e1-8.

  2. Tredway D, Schertz JC, Bock D, Hemsey G, Diamond MP. Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study. Fertil Steril 2011;95:1720-4.e1-8.

  3. Misso ML, Wong JL, Teede HJ, Hart R, Rombauts L, Melder AM, Norman RJ, Costello MF. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012;18:301-312.

  4. Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril 2012;98:1352-1355.

  5. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305-309.

  6. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005;84:s85.

  7. Tulandi T, Martin J, Al-Fadhli R, Kabli N, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85:1761-1765.

  8. Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 2009;88:187-191.

  9. Malloch L, Rhoton-Vlasak A. An assessment of current clinical attitudes toward letrozole use in reproductive endocrinology practices. Fertil Steril 2013;100:1740-1744.

  10. González-Becerra JE, Moreno-García JD, Sondón-García ZG, Regalado-Hernández MA. Efecto de la administración de LH recombinante en día 5 contra día 8 en ciclos de estimulación ovárica. Ginecol Obstet Mex 2013;81:440-447.

  11. Franik S, Kremer JA, Nelen WL, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014;2:CD010287.

  12. Legro RS, Brzyski RG, Diamond MP, Coutifaris C,et al; NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014;371:119-129.

  13. Diamond MP, Mitwally M, Casper R, Ager J, et al; NICHD Cooperative Reproductive Medicine Network. Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial. Contemp Clin Trials 2011;32:902-908.

  14. Diamond MP, Legro RS, Coutifaris C, Alvero R, et al; National Institute of Child Health and Human Development (NICHD) Reproductive Medicine Network. Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics. Fertil Steril 2015;103:962-973.e4.

  15. Clinical Trials Registry. Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation (AMIGOS). Disponible en: http://www.clinicaltrials.gov/ct2/show/NCT01044862 (accesado 18 de septiembre de 2014).




2020     |     www.medigraphic.com